| CYSB2400155 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products(原2) | Supplementary Application | 2024-06-18 | | Hisun Biopharmaceutical Co Ltd | | | view |
| JYSB2101039 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products | Supplementary Application | 2021-06-02 | | Abbvie Ltd;Vetter Pharma-Fertigung Gmbh & Co KG | | | view |
| JYSB2500243 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products | Supplementary Application | 2025-10-10 | | Vetter Pharma-Fertigung Gmbh & Co KG;Abbvie Deutschland Gmbh & Co KG | | | view |
| CYSB2200049 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products | Supplementary Application | 2022-02-16 | | Innovent Biologics (Suzhou) Co Ltd | | | view |
| CYSB2200090 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products | Supplementary Application | 2022-03-21 | | Nanjing Shunxin Pharmaceuticals Co LTDof Chiatai Tianqing Pharmaceutical Group;Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd | | | view |
| CYSB2200047 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products | Supplementary Application | 2022-02-15 | | Innovent Biologics (Suzhou) Co Ltd | | | view |
| CYSB2300140 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products | Supplementary Application | 2023-07-22 | | Innovent Biologics (Suzhou) Co Ltd | | | view |
| CYSB2101077 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products | Supplementary Application | 2021-05-27 | | Hisun Biopharmaceutical Co Ltd | | | view |
| CYSB2500074 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products(原2) | Supplementary Application | 2025-04-03 | | Shanghai Fuhong Ruilin Biotechnology Co Ltd;Shanghai Henlius Biopharmaceutical Co Ltd | | | view |
| CYSB2400052 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products(原2) | Supplementary Application | 2024-02-29 | | Shanghai Henlius Biopharmaceutical Co Ltd | | | view |
| CYSB2500208 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products | Supplementary Application | 2025-09-13 | | Innovent Biologics (Suzhou) Co Ltd | | | view |
| CYSB2200087 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products | Supplementary Application | 2022-03-21 | | Nanjing Shunxin Pharmaceuticals Co LTDof Chiatai Tianqing Pharmaceutical Group;Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd | | | view |
| JYSB2500241 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products | Supplementary Application | 2025-10-10 | | Vetter Pharma-Fertigung Gmbh & Co KG;Abbvie Deutschland Gmbh & Co KG | | | view |
| CYSB2200205 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products(3.3) | Supplementary Application | 2022-08-19 | | Shanghai Junshi Biosciences Co Ltd;Suzhou UNION Biopharm Biosciences Co Ltd | | | view |
| CYSB2400125 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products(3.3) | Supplementary Application | 2024-05-22 | | SinoCelltech Ltd | | | view |
| CYSB2300080 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products(原2) | Supplementary Application | 2023-04-11 | | Shanghai Henlius Biopharmaceutical Co Ltd | | | view |
| JYSB2101038 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products | Supplementary Application | 2021-06-02 | | Abbvie Ltd;Vetter Pharma-Fertigung Gmbh & Co KG | | | view |
| CXSS2400138 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products(3.3) | New Drug Application | 2024-12-14 | | Zhejiang HUAHAI Biopharmaceuticals Co Ltd | | | view |
| JYSZ2100520 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products | License Renew | 2021-06-10 | | Abbvie Ltd;AbbVie Pharmaceutical Trading (Shanghai) Co Ltd | | | view |
| CYSB2400049 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products(原2) | Supplementary Application | 2024-02-29 | | Shanghai Henlius Biopharmaceutical Co Ltd | | | view |
